Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
Lexiscan, Rapiscan, regadenoson (CVT-3146)
print preview
bookmark
share with colleague
General Information
Company
Gilead Sciences Inc.
Description
Short-acting adenosine A2A receptor (ADORA2A) agonist
Molecular Target
Adenosine A2A receptor (ADORA2A)
Mechanism of Action
Adenosine A2A receptor agonist; Diagnostic
Latest Stage of Development
Marketed
Indication
Cardiovascular, Diagnostic
Partner
Astellas Pharma Inc.
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy